Zobrazeno 1 - 10
of 8 566
pro vyhledávání: '"D2 agonist"'
Publikováno v:
Chemistry, Vol 3, Iss 3, Pp 1047-1056 (2021)
The dopamine D2 agonist MCL-524 is selective for the D2 receptor in the high-affinity state (D2high), and, therefore, the PET analogue, [18F]MCL-524, may facilitate the elucidation of the role of D2high in disorders such as schizophrenia. However, th
Externí odkaz:
https://doaj.org/article/5a1916e91d404f2aa0245d4f9b0a550a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 3, Pp 405-415 (2021)
Abstract Aim A reduced mismatch negativity (MMN) response is a promising electrophysiological endophenotype of schizophrenia that reflects neurocognitive impairment. Dopamine dysfunction is associated with symptoms of schizophrenia. However, whether
Externí odkaz:
https://doaj.org/article/cf35f85945dd47f9ab17174684b30460
Autor:
Inaba, Hiroyoshi1,2 (AUTHOR) hiroyoshi.inaba@gmail.com, Namba, Hisaaki1,3 (AUTHOR), Kida, Satoshi2 (AUTHOR), Nawa, Hiroyuki1,3 (AUTHOR)
Publikováno v:
Neuropsychopharmacology Reports. Sep2021, Vol. 41 Issue 3, p405-415. 11p.
Autor:
Boonstra, E.A1,2 (AUTHOR) evertboonstra@gmail.com, van Schouwenburg, M.R2 (AUTHOR), Seth, A.K3,4 (AUTHOR), Bauer, M5 (AUTHOR), Zantvoord, J.B6 (AUTHOR), Kemper, E.M7 (AUTHOR), Lansink, C.S8 (AUTHOR), Slagter, H.A1,2 (AUTHOR)
Publikováno v:
Psychopharmacology. Sep2020, Vol. 237 Issue 9, p2855-2872. 18p. 2 Black and White Photographs, 2 Diagrams, 1 Chart, 8 Graphs.
Publikováno v:
Chemistry
Volume 3
Issue 3
Pages 75-1056
Chemistry, Vol 3, Iss 75, Pp 1047-1056 (2021)
Volume 3
Issue 3
Pages 75-1056
Chemistry, Vol 3, Iss 75, Pp 1047-1056 (2021)
The dopamine D2 agonist MCL-524 is selective for the D2 receptor in the high-affinity state (D2high), and, therefore, the PET analogue, [18F]MCL-524, may facilitate the elucidation of the role of D2high in disorders such as schizophrenia. However, th
Autor:
Weber, Martin, Chang, Wei-Li, Breier, Michelle R., Yang, Alex, Millan, Mark J., Swerdlow, Neal R.
Publikováno v:
In European Neuropsychopharmacology 2010 20(6):421-425
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Neuropsychopharmacology Reports
Aim A reduced mismatch negativity (MMN) response is a promising electrophysiological endophenotype of schizophrenia that reflects neurocognitive impairment. Dopamine dysfunction is associated with symptoms of schizophrenia. However, whether the dopam
Autor:
Sabzehkhah, S.1, Vaezi, Gh.H.1, Bakhtiarian, A.2, Salarian, A.2 salariana@yahoo.com, Haghighi, M. Zare2
Publikováno v:
Tehran University Medical Journal. Nov2009, Vol. 67 Issue 8, p535-541. 7p.